1.15
price down icon2.54%   -0.03
after-market 시간 외 거래: 1.15
loading
전일 마감가:
$1.18
열려 있는:
$1.18
하루 거래량:
235.93K
Relative Volume:
1.21
시가총액:
$61.01M
수익:
-
순이익/손실:
$-13.08M
주가수익비율:
-2.6042
EPS:
-0.4416
순현금흐름:
-
1주 성능:
-32.35%
1개월 성능:
-43.63%
6개월 성능:
-74.56%
1년 성능:
-69.33%
1일 변동 폭
Value
$1.15
$1.20
1주일 범위
Value
$1.15
$1.68
52주 변동 폭
Value
$1.15
$8.40

Telomir Pharmaceuticals Inc Stock (TELO) Company Profile

Name
명칭
Telomir Pharmaceuticals Inc
Name
전화
786-396-6723
Name
주소
100 SE 2ND ST, MIAMI
Name
직원
5
Name
트위터
Name
다음 수익 날짜
2024-11-11
Name
최신 SEC 제출 서류
Name
TELO's Discussions on Twitter

TELO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
TELO
Telomir Pharmaceuticals Inc
1.15 61.01M 0 -13.08M 0 -0.4416
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.62 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.36 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
331.91 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
543.48 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.49 28.51B 3.81B -644.79M -669.77M -6.24

Telomir Pharmaceuticals Inc Stock (TELO) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-02-21 개시 Rodman & Renshaw Buy

Telomir Pharmaceuticals Inc 주식(TELO)의 최신 뉴스

pulisher
Jun 18, 2025

TELO Rises on Promising Telomir-1 Preclinical Results - MSN

Jun 18, 2025
pulisher
Jun 18, 2025

Telomir Pharmaceuticals Prevents Cellular Aging in Patient-Derived Cells from Children with Progeriaan Ultra-Rare Genetic Disorder that Causes Rapid Aging - Knoxville News Sentinel

Jun 18, 2025
pulisher
Jun 18, 2025

# Telomir-1 shows anti-aging effects in progeria cell study By Investing.com - Investing.com South Africa

Jun 18, 2025
pulisher
Jun 18, 2025

Telomir Pharmaceuticals reports positive results for progeria treatment By Investing.com - Investing.com South Africa

Jun 18, 2025
pulisher
Jun 18, 2025

Telomir Pharmaceuticals reports positive results for progeria treatment - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

# Telomir-1 shows anti-aging effects in progeria cell study - Investing.com Australia

Jun 18, 2025
pulisher
Jun 18, 2025

Telomir Pharmaceuticals IncTelomir-1 Significantly Increased Cell ViabilitySEC Filing - MarketScreener

Jun 18, 2025
pulisher
Jun 18, 2025

Revolutionary Progeria Treatment Shows First-Ever Cellular Aging Prevention in Children's Cells - Stock Titan

Jun 18, 2025
pulisher
Jun 18, 2025

EXCLUSIVE: Telomir Pharmaceuticals Says Preclinical Drug Candidate Prevents Premature Aging In Patient-Derived Cells From Children With Progeria - Benzinga

Jun 18, 2025
pulisher
Jun 13, 2025

10 Best Growth Stocks Under $100 to Buy Now - Insider Monkey

Jun 13, 2025
pulisher
Jun 12, 2025

Telomir Pharmaceuticals Announces Telomir-1 Demonstrates Dose-Dependent Restoration of Neurological, Liver and Kidney Functions in Preclinical Wilson's Disease Model - The Oklahoman

Jun 12, 2025
pulisher
Jun 11, 2025

Telomir-1 shows promise in reversing Wilson’s disease symptoms By Investing.com - Investing.com South Africa

Jun 11, 2025
pulisher
Jun 11, 2025

Telomir Pharmaceuticals reports promising drug trial results By Investing.com - Investing.com South Africa

Jun 11, 2025
pulisher
Jun 11, 2025

Telomir Pharmaceuticals reports promising drug trial results - Investing.com

Jun 11, 2025
pulisher
Jun 11, 2025

Telomir Pharmaceuticals Says Positive Preclinical Results For Telomir-1 In Wilson'S Disease Animal Model - MarketScreener

Jun 11, 2025
pulisher
Jun 11, 2025

Telomir-1 shows promise in reversing Wilson’s disease symptoms - Investing.com Australia

Jun 11, 2025
pulisher
Jun 11, 2025

Breakthrough Wilson's Disease Treatment Reverses Brain, Liver, and Kidney Damage in Preclinical Study - Stock Titan

Jun 11, 2025
pulisher
Jun 07, 2025

Nuveen Asset Management LLC Purchases New Shares in Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

Telomir Pharmaceuticals Announces Telomir-1 Resets the Body's Epigenetic Clock, Reverses DNA Methylation, and Restores Youthful Gene Regulation in an Ultra-Rare Accelerated Aging Animal Model of Werner Syndrome - Reno Gazette Journal

Jun 05, 2025
pulisher
Jun 05, 2025

telomir pharmaceuticals reports promising preclinical results for telomir-1 By Investing.com - Investing.com South Africa

Jun 05, 2025
pulisher
Jun 05, 2025

EXCLUSIVE: Telomir Pharmaceuticals Lead Drug Shows Promising Signs In Animal Study For Rare Premature Aging Disorder - AOL.com

Jun 05, 2025
pulisher
Jun 05, 2025

Telomir Says Lead Candidate Telomir-1 Restored Gene Regulation in Animal Model of Werner Syndrome - MarketScreener

Jun 05, 2025
pulisher
Jun 05, 2025

telomir pharmaceuticals reports promising preclinical results for telomir-1 - Investing.com

Jun 05, 2025
pulisher
Jun 05, 2025

Telomir Pharmaceuticals-New Data From Preclinical Study Of Its Lead Compound, Telomir-1, In Validated Animal Model Of Werner Syndrome - marketscreener.com

Jun 05, 2025
pulisher
Jun 05, 2025

Revolutionary Anti-Aging Drug Resets Biological Clock, Reverses Multiple Aging Markers in Landmark Study - Stock Titan

Jun 05, 2025
pulisher
Jun 03, 2025

Telomir Pharmaceuticals Joins BIO Convention for Partnerships - MSN

Jun 03, 2025
pulisher
Jun 03, 2025

Telomir announces positive preclinical data for its novel oral AMD therapeutic - Ophthalmology Times

Jun 03, 2025
pulisher
Jun 03, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Increases Position in Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Telomir Pharmaceuticals to Participate in BIO 2025 in Boston as Company Prepares for IND Submission and Advances Breakthrough Longevity Platform - Cheboygan Daily Tribune

Jun 03, 2025
pulisher
Jun 02, 2025

Telomir Pharmaceuticals To Present At BIO 2025, Eyes IND Filing For Telomir-1 - Nasdaq

Jun 02, 2025

Telomir Pharmaceuticals Inc (TELO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
자본화:     |  볼륨(24시간):